MeiraGTx Signs J&J To Develop Gene Therapies For Rare Retinal Diseases

 
• By Joseph Haas

While it wants to keep other programs for diseases with larger patient populations in house, MeiraGTx believes J&J offers the global reach to expedite its program in inherited retinal diseases, including three clinical candidates.

Ishihara Test. Color Blind Test. - Vector
A test used to diagnose color blindness, part of the symptomology of achromatopsia.

More from Deals

More from Business